| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.697 | 31.651 | 38.849 | 46.182 | 47.900 | 50.039 | 57.124 | 76.648 | 86.813 |
| Total Income - EUR | - | 12.697 | 31.651 | 38.850 | 46.186 | 49.968 | 50.039 | 57.125 | 76.649 | 86.933 |
| Total Expenses - EUR | - | 9.736 | 19.553 | 20.220 | 23.415 | 33.334 | 29.397 | 36.436 | 43.221 | 49.386 |
| Gross Profit/Loss - EUR | - | 2.960 | 12.098 | 18.630 | 22.771 | 16.634 | 20.642 | 20.689 | 33.428 | 37.547 |
| Net Profit/Loss - EUR | - | 2.833 | 11.782 | 18.242 | 22.334 | 16.373 | 20.385 | 20.315 | 32.835 | 34.993 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Davmed Oms Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 5.849 | 3.971 | 2.164 | 423 | 1.510 | 21.073 | 31.644 |
| Current Assets | - | 3.729 | 12.751 | 17.514 | 20.537 | 26.529 | 36.291 | 43.077 | 35.522 | 35.934 |
| Inventories | - | 0 | 0 | 251 | 0 | 0 | 0 | 0 | 0 | 179 |
| Receivables | - | 2.390 | 3.063 | 3.205 | 4.046 | 4.141 | 3.861 | 4.456 | 11.540 | 170 |
| Cash | - | 1.339 | 9.688 | 14.058 | 16.491 | 22.388 | 32.430 | 38.621 | 23.981 | 35.584 |
| Shareholders Funds | - | 2.878 | 11.826 | 21.720 | 22.418 | 26.790 | 34.856 | 42.237 | 45.498 | 45.712 |
| Social Capital | - | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 851 | 925 | 1.643 | 2.090 | 1.904 | 1.859 | 2.350 | 11.097 | 21.867 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Davmed Oms Srl